Lipoprotein(a) is not a causal factor for the development of diabetes - a two-sample Mendelian randomization study.

27 August 2023 (10:45 - 10:55)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Associate Professor Tadeusz Osadnik

Medical University of Silesia in Katowice, Zabrze (Poland)

5 More presentations in this session

Presentation thumbnail

Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: a meta-analysis of 59 trials

Doctor P. Burger (Utrecht, NL)

Abstract Slides Video

Presentation thumbnail

An investigational in vivo base editing medicine targeting ANGPTL3, VERVE-201, achieves potent and LDLR-independent liver editing in mouse models

Doctor A. Khera (Boston, US)

Abstract Slides Video

Presentation thumbnail

Attainment of LDL-cholesterol goals in patients with previous myocardial infarction: a real-world cross-sectional analysis

Mr D. Gomes (Lisbon, PT)

Abstract Slides Video

Presentation thumbnail

Cardiovascular outcomes in patients with coronary artery disease and elevated lipoprotein(a): Implications for the OCEAN(a)-Outcomes trial population

Doctor B. Weber (Dallas, US)

Abstract Slides Video

Presentation thumbnail

Effects of icosapent ethyl on residual cardiovascular risk according to predicted baseline risk: results from REDUCE-IT

Doctor P. Burger (Utrecht, NL)

Abstract Slides Video

Access the full session

Session thumbnail

What's new in lipid lowering?

The Event

Event poster

ESC Congress 2023

27 August 2023 10:45 CET

You may be interested in

Congress Presentation

Genetically determined lipoprotein(a) levels do not cause an increased risk of preeclampsia - a two-sample Mendelian randomization study.

Congress Presentation

Causal associations of insulin and Lp(a) levels: a Mendelian randomization study

Congress Session

Controversies in lipoprotein(a)

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources